Stockreport

Forte Biosciences Announces Proposed Public Offering

Forte Biosciences, Inc.  (FBRX) 
PDF DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, to [Read more]